SHANTA MARY ZIMMER, M.D.
Osteopathic Medicine at Clairmont Rd, Decatur, GA

License number
Georgia 046289
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address 2
1670 Clairmont Rd, Decatur, GA 30033
1754 Ridgewood Dr NE, Atlanta, GA 30307
Phone
(404) 321-6111

Personal information

See more information about SHANTA MARY ZIMMER at radaris.com
Name
Address
Phone
Shanta M Zimmer
1865 R Idlewood Dr, Atlanta, GA 30344
Shanta M Zimmer
12206 Jefferson Square Ct, Decatur, GA 30030
(404) 296-3942
Shanta M Zimmer
4955 Guerry Dr, Macon, GA 31210
Shanta M Zimmer
2 W Court Sq, Decatur, GA 30030
Shanta M Zimmer
2825 NE Expressway #G4, Atlanta, GA 30345

Professional information

See more information about SHANTA MARY ZIMMER at trustoria.com
Shanta M Zimmer Photo 1
Dr. Shanta M Zimmer, Pittsburgh PA - MD (Doctor of Medicine)

Dr. Shanta M Zimmer, Pittsburgh PA - MD (Doctor of Medicine)

Specialties:
Infectious Disease Medicine
Address:
200 Lothrop St, Pittsburgh 15213
1670 Clairmont Rd, Decatur 30033
(404) 321-6111 (Phone)
Certifications:
Infectious Disease, 2003, Internal Medicine, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
200 Lothrop St, Pittsburgh 15213
1670 Clairmont Rd, Decatur 30033
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
Education:
Medical School
Emory University
Graduated: 1997
Emory University School Of Med


Shanta Zimmer Photo 2
Neisseria Mutants, Lipooligosaccharides And Immunogenic Compositions

Neisseria Mutants, Lipooligosaccharides And Immunogenic Compositions

US Patent:
7807181, Oct 5, 2010
Filed:
Mar 20, 2003
Appl. No.:
10/508309
Inventors:
David S. Stephens - Stone Mountain GA, US
Yih-Ling Tzeng - Atlanta GA, US
Susu Zughaier - Atlanta GA, US
Shanta Zimmer - Atlanta GA, US
Assignee:
Emory University - Atlanta GA
International Classification:
A61K 39/02, A61K 39/095, A61K 39/38, A01N 43/04, C07H 1/00
US Classification:
4242341, 4241841, 4242501, 4242491, 514 23, 5361231
Abstract:
Provided herein are mutant strains of which produce Kdo-free lipid A as well as the Kdo-free lipid A molecules and immunogenic compositions containing such Kdo-free lipid A molecules from a strain containing a genetically stable mutation which inactivates a gene selected from the group consisting of genes encoding arabinose-5-phosphate isomerase, CMP-Kdo synthetase and CMP-Kdo transferase. NMB206 is a specifically exemplified strain which harbors a stable insertion mutation in the gene (kpsF) encoding A5P isomerase; strain NMB-249 is a specifically exemplified strain with a stable insertion mutation in the gene (kdtA) encoding CMP-Kdo synthetase, and strain NMB259 is specifically exemplified strain with a stable insertion mutation in the gene (kdsB) encoding CMP-Kdo transferase. Also provided by the present invention are methods for the production of Lipid A flee of 3-keto-3-deoxyoctanoic acid using these genetically stable mutants. Also describes is pYT250, a plasmid functional in neisseriae and in enterics such as.